Giuseppe
Emeritus
[Source: Emerging Infectious Diseases Journal, full text: (LINK). Abstract, edited.]
--------
Volume 17, Number 8?August 2011
Dispatch
Poliomyelitis Outbreak, Pointe-Noire, Republic of the Congo, September 2010?February 2011
Arnaud Le Menach, Augusto E. Llosa, Isabelle Mouniaman-Nara, Felix Kouassi, Joseph Ngala, Naomi Boxall, Klaudia Porten, and Rebecca F. Grais
Author affiliations: Health Protection Agency, London, UK (A. Le Menach, N. Boxall); European Centre for Disease Control and Prevention, Stockholm, Sweden (A. Le Menach); Epicentre, Paris, France (A.E. Llosa, K. Porten, R. F. Grais); M?decins Sans Fronti?res, Paris (I. Mouniaman-Nara, F. Kouassi); M?decins Sans Fronti?res, Brazzaville, Republic of the Congo (I. Mouniaman-Nara, F. Kouassi); and Ministry of Health, Pointe-Noire, Republic of the Congo (J. Ngala)
Abstract
On November 4, 2010, the Republic of the Congo declared a poliomyelitis outbreak. A cross-sectional survey in Pointe-Noire showed poor sanitary conditions and low vaccination coverage (55.5%), particularly among young adults. Supplementary vaccination should focus on older age groups in countries with evidence of immunity gaps.
-Dispatch
Poliomyelitis Outbreak, Pointe-Noire, Republic of the Congo, September 2010?February 2011
Arnaud Le Menach, Augusto E. Llosa, Isabelle Mouniaman-Nara, Felix Kouassi, Joseph Ngala, Naomi Boxall, Klaudia Porten, and Rebecca F. Grais
Author affiliations: Health Protection Agency, London, UK (A. Le Menach, N. Boxall); European Centre for Disease Control and Prevention, Stockholm, Sweden (A. Le Menach); Epicentre, Paris, France (A.E. Llosa, K. Porten, R. F. Grais); M?decins Sans Fronti?res, Paris (I. Mouniaman-Nara, F. Kouassi); M?decins Sans Fronti?res, Brazzaville, Republic of the Congo (I. Mouniaman-Nara, F. Kouassi); and Ministry of Health, Pointe-Noire, Republic of the Congo (J. Ngala)
Abstract
On November 4, 2010, the Republic of the Congo declared a poliomyelitis outbreak. A cross-sectional survey in Pointe-Noire showed poor sanitary conditions and low vaccination coverage (55.5%), particularly among young adults. Supplementary vaccination should focus on older age groups in countries with evidence of immunity gaps.
--------